Allogenetics GmbH
Germany
activeseed
seed
Stage
2023
Founded
1
Investors
About
Allogenetics develops a transplantation technology that addresses organ rejection by modifying the donor organ to become immunologically invisible, eliminating the need for lifelong immunosuppression and improving graft survival and patient quality of life.
Explore Allogenetics GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.